VOTIS Subdermal Imaging Technologies Company
VOTIS Subdermal Imaging Technologies help diabetics keep their feet through early screening for peripheral vascular disease and related complications. Early screening can offer new treatment options and help reduce incidents of amputation. Their device is non-invasive and contact-free, not based on radiation, and functionally consistent with the guidelines of the AHA, the American Diabetes Association, and other leading medical organizations. It will reduce healthcare costs for hospitals, clinics, and insurers.
Industry:
Biomarkers for Longevity
Headquarters:
Jerusalem, Yerushalayim, Israel
Zip:
1-10
Founded Date:
2017-01-01
Employees Number:
1-10
Acquisitions Number:
1
Investors Number:
2500000
Total Funding:
2500000
Last Funding Date:
Seed
Last Funding Type:
merrillweber@votis.net
Register and Claim Ownership